MENU
JANX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Janux Therapeutics (JANX) Earnings Date & Reports

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer... Show more

A.I. Advisor
published Earnings

JANX is expected to report earnings to rise 2.03% to -36 cents per share on May 13

Janux Therapeutics JANX Stock Earnings Reports
Q1'25
Est.
$-0.37
Q4'24
Beat
by $0.07
Q3'24
Missed
by $0.18
Q2'24
Beat
by $0.20
Q1'24
Beat
by $0.04
The last earnings report on February 27 showed earnings per share of -36 cents, beating the estimate of -42 cents. With 390.46K shares outstanding, the current market capitalization sits at 1.67B.
View a ticker or compare two or three
JANX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
10955 Vista Sorrento Parkway
Phone
+1 858 751-4493
Employees
64
Web
https://www.januxrx.com